Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sanger Human Cell Atlasing Project. Defining Human Cells in Terms of Gene Expression, Physiological States,Developmental Trajectories, and Location.

NCT06497673 is registered in ClinicalTrials.gov with The Wellcome Sanger Institute as lead sponsor.

NCT NCT06497673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06497673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sanger Human Cell Atlasing Project. Defining Human Cells in Terms of Gene Expression, Physiological States,Developmental Trajectories, and Location.
Lead sponsor
The Wellcome Sanger Institute
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 16, 2019
Completion date
November 7, 2029
Enrollment
4,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic disease, human development